Page 40 – Latest News ,whitepapers ,webinar, articles about healthcare

BioIntelliSense Joins Polaris Dawn Mission to Advance…

admin Nov 15, 2022 0

BioIntelliSense, Inc., a continuous health monitoring and clinical intelligence company, today announced its…

Articles

HealthTab™ Enters Multi-Year Collaboration Agreement with Abbott for Point-of-Care Testing Across the UK

2026-08-20T10:30:00Z

VANCOUVER, British Columbia, Aug. 20, 2026 (GLOBE NEWSWIRE) -- AVRICORE HEALTH INC. (TSXV: AVCR) is pleased to announce that its wholly-owned subsidiary, HealthTab Ltd, has entered into a formal collaboration...

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement

2026-08-20T09:31:58Z

NANJING, China, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced that the full abstract of the Phase...

BioNTech Highlights Late-Stage Lung Cancer Pipeline Momentum and First Global Data for Pumitamig/Elfetabart Drozuntecan Novel-Novel Combination at WCLC 2026

2026-08-20T09:30:00Z

MAINZ, Germany, August 20, 2026 – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will present new clinical data from its diversified development program in lung cancer treatment at the IASLC 2026...

BioPorto announces Interim Results for the Second Quarter and First half of 2026

2026-08-20T05:55:20Z

August 20, 2026Announcement no. 14

Vistin Pharma ASA: Second quarter and YTD 2026 financial results

2026-08-20T05:45:00Z

Oslo, Norway, 20 August 2026

ALK appoints Jacob Glenting as head of Global R&D

2026-08-20T05:33:00Z

ALK announces the appointment of Jacob Glenting as new Executive Vice President (EVP) and head of Global R&D, effective 1 September 2026. This position has been vacant since February 2026....

Six-month interim report (Q2) 2026 (unaudited)

2026-08-20T05:30:00Z

ALK delivers 18% organic revenue growth with operating profit (EBIT) up 19% in Q2

Zelluna ASA: Second Quarter 2026 results

2026-08-20T05:00:00Z

Oslo, 20 August 2026 – Zelluna (OSE: ZLNA), a clinical-stage company pioneering allogeneic "off-the-shelf" T Cell Receptor-based Natural Killer (TCR-NK) cell therapies for the treatment of solid cancers, today presents...

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Abstract Published by WCLC: Extended Follow‑Up Shows Continued Efficacy Improvement

2026-08-20T02:53:18Z

NANJING, China, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Nanjing Leads Biolabs Co., Ltd. (“Leads Biolabs” or the “Company,” Stock Code: 9887.HK) today announced that the full abstract of the Phase...

Edesa Biotech Announces Pricing of $25.0 Million Public Offering

2026-08-20T02:20:00Z

TORONTO, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Edesa Biotech, Inc. (Nasdaq: EDSA) (the “Company” or “Edesa”), a clinical-stage biopharmaceutical company focused on developing host-directed therapeutics for immuno-inflammatory diseases, today announced...

Telix 2026 Half-Year Results: Strong Commercial Execution and Momentum in Late-Stage Pipeline

2026-08-20T00:32:23Z

MELBOURNE, Australia and INDIANAPOLIS, Aug. 20, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, "Telix") today announces its financial results for the period ended June 30, 2026.

Ascentage Pharma Reports 2026 Interim Unaudited Financial Results and Provides Business Updates

2026-08-19T23:00:00Z

ROCKVILLE, Md., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Ascentage Pharma Group International (Ascentage Pharma) (NASDAQ: AAPG; HKEX: 6855) (referred hereinto as “Ascentage Pharma,” the “Company,” “we,” “us” or “our”), a...

Picard Medical Reports Second Quarter 2026 Financial Results

2026-08-19T21:30:00Z

-Revenue Increases 39% and Net Loss Decreases 16%-

Ultragenyx Announces U.S. FDA Approval of GENGLYCOS™ Gene Therapy, the First-Ever FDA-Approved Treatment Designed to Treat the Underlying Cause of Glycogen Storage Disease Type Ia (GSDIa)

2026-08-19T21:21:23Z

GENGLYCOS is the first gene therapy approval, and fifth FDA approval overall, for the company

Solésence Reports Second Quarter 2026 Financial Results

2026-08-19T21:05:00Z

Quarterly Report Filed on Form 10-Q

Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update

2026-08-19T20:30:00Z

REYKJAVIK, ICELAND (August 19, 2026) — Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for patients worldwide,...

Alvotech Announces Financial Results for the First Half of 2026 and Provides a Business Update

2026-08-19T20:30:00Z

REYKJAVIK, Iceland, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Alvotech (NASDAQ: ALVO; ALVO-SDB) (“Alvotech” or the “Company”), a global biotechnology company specializing in the development and manufacture of biosimilar medicines for...

Dr. Jacqueline Youtsos Expands Access to Dermatology and Medical Aesthetics with ReNu Medical & Spa in Parsons

2026-08-19T20:15:10Z

PARSONS, Kan., Aug. 19, 2026 (GLOBE NEWSWIRE) -- {{DATELINECITY_DATE_GLOBENEWSWIRE_BUG}ReNu Medical & Spa is proud to announce the opening of its newest location in Parsons, Kansas, expanding access to high-quality dermatology...

DNA X, Inc. Reports Second Quarter 2026 Financial Results

2026-08-19T20:15:00Z

-Strengthened balance sheet with $1.8 million cash from new convertible debt in Q2 and additional $5.0 million through the sale of preferred stock after quarter end

Regeneron Announces Investor Conference Presentations

2026-08-19T20:05:00Z

TARRYTOWN, N.Y., Aug. 19, 2026 (GLOBE NEWSWIRE) -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) will webcast management participation as follows:

Merit Medical Announces Global Operations Leadership Transition

2026-08-19T20:05:00Z

SOUTH JORDAN, Utah, Aug. 19, 2026 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading global manufacturer of healthcare technology, today announced that Sheri Lewis has agreed to...

- Latest News ,whitepapers ,webinar, articles about healthcare

How the New Gen Z Generation Is Focusing on a Healthier and Fitter Lifestyle

Medicinal Cannabis in Australia: Science, Regulation & Industry

Organizing for analytics in health care

Improving Patient Care, Reducing Costs

Hair Fall and Obesity in Today’s Generation: How Modern Lifestyle Is Affecting Our Health

BioIntelliSense Joins Polaris Dawn Mission to Advance…